Vaishali Pharma responded to an NSE query regarding recent stock price and volume movement.
The company confirmed no undisclosed price-sensitive information caused the market activity.
All material disclosures were made per SEBI LODR Regulation 30 requirements.
Attributed the price fluctuation solely to market-driven conditions.